On minimum cyclic AMP formation rates associated with positive inotropic effects mediated through beta 1-adrenoceptors in kitten myocardium. Beta 1-specific and non-adrenergic stimulant effects of denopamine
- PMID: 2566921
- DOI: 10.1007/BF00165133
On minimum cyclic AMP formation rates associated with positive inotropic effects mediated through beta 1-adrenoceptors in kitten myocardium. Beta 1-specific and non-adrenergic stimulant effects of denopamine
Abstract
The agonist (-)-denopamine was used as a tool to study relationships between pharmacological effects and adenylate cyclase stimulation mediated through beta 1-adrenoceptors. 1. (-)-Denopamine was a full agonist in kitten papillary muscles (force), kitten left atria (force) and kitten and guinea-pig atria (sinoatrial frequency). (-)-Denopamine was a strong partial agonist in guinea-pig tracheae (relaxation). None of these effects was influenced by blockade of beta 2-adrenoceptors. beta 1-Adrenoceptors mediated all effects of (-)-denopamine in atria and effects of low (-)-denopamine concentrations in papillary muscles and tracheae, as assessed with beta 1-selective antagonists. 2. High (-)-denopamine concentrations caused positive inotropic effects in papillary muscles and tracheorelaxant effects that were resistant to blockade by beta 1-, beta 2- and alpha-adrenoceptor antagonists (non-adrenergic effects). 3. (-)-Denopamine stimulated the adenylate cyclase of membranes derived from kitten ventricle and calf tracheal cells with an intrinsic activity of 0.3 and 0.2, respectively, compared to catecholamines. The contribution of beta 1- and beta 2-adrenoceptors to cyclase stimulation was assessed by selective blockade. Cyclase stimulation through beta 2-adrenoceptors by (-)-denopamine was 12% in ventricle and 82% in trachea but is not associated with positive inotropic effects and tracheal relaxation. 4. (-)-Denopamine exhibited only a 2- to 5-fold selectivity for beta 1-adrenoceptors compared to beta 2-adrenoceptors, as estimated consistently from binding assays and blockade of cyclase stimulation in myocardial and tracheal cell membranes. 5. Desensitization of kitten ventricular tissues, caused by a 3 h exposure to 30 mumol/l (-)-isoprenaline followed by 5 h washout, reduced the inotropic sensitivity of papillary muscles without decreasing the maximum inotropic effects of (-)-denopamine. In desensitized tissues, the nonadrenergic effect contributed by 30% to the maximum inotropic effect of (-)-denopamine. 6. In membranes, derived from desensitized tissues, the maximum adenylate cyclase stimulation induced by (-)-isoprenaline, (-)-denopamine and xamoterol was reduced to 1/2 of the corresponding stimulations observed in membranes from sham desensitized tissues. The density of beta-adrenoceptors, assessed with 3H-(-)-CGP 12,177, was not changed by the desensitization procedure suggesting that part of the receptors was uncoupled from the adenylate cyclase. The partial inotropic agonist xamoterol, which has an intrinsic activity of 0.5 in non-desensitized tissues, failed to cause positive inotropic effects in desensitized papillary muscles suggesting that not all cyclic AMP possesses inotropic relevance.(ABSTRACT TRUNCATED AT 400 WORDS)
Similar articles
-
Selective and full beta 1-adrenoceptor agonist action of a catechol derivative of denopamine (T-0509) in the guinea-pig cardiac muscle and trachea: comparison with denopamine, xamoterol and isoprenaline.Br J Pharmacol. 1992 Jun;106(2):335-41. doi: 10.1111/j.1476-5381.1992.tb14337.x. Br J Pharmacol. 1992. PMID: 1356559 Free PMC article.
-
Xamoterol activates beta 1- but not beta 2-adrenoceptors in mammalian myocardium: comparison of its affinity for beta 1- and beta 2-adrenoceptors coupled to the adenylate cyclase in feline and human ventricle with positive inotropic effects.J Cardiovasc Pharmacol. 1989 Jan;13(1):105-17. J Cardiovasc Pharmacol. 1989. PMID: 2468921
-
Direct labelling of myocardial beta 1-adrenoceptors. Comparison of binding affinity of 3H-(-)-bisoprolol with its blocking potency.Naunyn Schmiedebergs Arch Pharmacol. 1985 Oct;331(1):27-39. doi: 10.1007/BF00498849. Naunyn Schmiedebergs Arch Pharmacol. 1985. PMID: 2866449
-
The functional importance of beta 1 and beta 2 adrenoceptors in the human heart.Am J Cardiol. 1988 Aug 11;62(5):24C-29C. doi: 10.1016/s0002-9149(88)80063-8. Am J Cardiol. 1988. PMID: 2900601 Review.
-
Proposal for the interaction of non-conventional partial agonists and catecholamines with the 'putative beta 4-adrenoceptor' in mammalian heart.Clin Exp Pharmacol Physiol. 1997 Sep-Oct;24(9-10):647-56. doi: 10.1111/j.1440-1681.1997.tb02107.x. Clin Exp Pharmacol Physiol. 1997. PMID: 9315364 Review.
Cited by
-
Relations between beta-adrenoceptor occupancy and increases of contractile force and adenylate cyclase activity induced by catecholamines in human ventricular myocardium. Acute desensitization and comparison with feline ventricle.Naunyn Schmiedebergs Arch Pharmacol. 1989 Jan-Feb;339(1-2):99-112. doi: 10.1007/BF00165132. Naunyn Schmiedebergs Arch Pharmacol. 1989. PMID: 2542808
-
Selective and full beta 1-adrenoceptor agonist action of a catechol derivative of denopamine (T-0509) in the guinea-pig cardiac muscle and trachea: comparison with denopamine, xamoterol and isoprenaline.Br J Pharmacol. 1992 Jun;106(2):335-41. doi: 10.1111/j.1476-5381.1992.tb14337.x. Br J Pharmacol. 1992. PMID: 1356559 Free PMC article.
-
Regional differences of beta 1- and beta 2-adrenoceptor-mediated functions in feline heart. A beta 2-adrenoceptor-mediated positive inotropic effect possibly unrelated to cyclic AMP.Naunyn Schmiedebergs Arch Pharmacol. 1991 Jul;344(1):56-69. doi: 10.1007/BF00167383. Naunyn Schmiedebergs Arch Pharmacol. 1991. PMID: 1685558
-
Modulation of L-type Ca current by denopamine, a nonparenteral partial beta 1 stimulant, in rabbit ventricular cells.Naunyn Schmiedebergs Arch Pharmacol. 1996 Oct;354(4):437-43. doi: 10.1007/BF00168434. Naunyn Schmiedebergs Arch Pharmacol. 1996. PMID: 8897446
-
Some aspects of heart beta adrenoceptor function.Cardiovasc Drugs Ther. 1991 Jun;5(3):549-60. doi: 10.1007/BF03029725. Cardiovasc Drugs Ther. 1991. PMID: 1652275 Review.
References
-
- J Pharmacol Exp Ther. 1980 Mar;212(3):503-8 - PubMed
-
- Mol Pharmacol. 1979 Sep;16(2):429-40 - PubMed
-
- Naunyn Schmiedebergs Arch Pharmacol. 1985 Oct;331(1):60-70 - PubMed
-
- Naunyn Schmiedebergs Arch Pharmacol. 1985 Oct;331(1):52-9 - PubMed
-
- Naunyn Schmiedebergs Arch Pharmacol. 1985 Oct;331(1):27-39 - PubMed